Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-25

Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers. [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating efficacy and safety of ALLO-ASC-DFU in diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: COMPLETED